This invention relates to new chemical compounds, application of these compound as thrombin inhibitors, and pharmaceutical compositions based on them, and can be used to treat and prevent thrombin-dependent thromboembolic events, and in research.
这项发明涉及新的化合物,这些化合物作为凝血酶
抑制剂的应用,以及基于它们的药物组合物,可用于治疗和预防依赖凝血酶的血栓栓塞事件,并用于研究。